Welcome to Markets Desk, your midday read on what's moving.
Options flow is telling a story today across several S&P five hundred names. JPMorgan is seeing elevated contract volume, with nearly twenty-nine thousand four hundred options changing hands — a signal that traders are positioning around the money center bank with conviction, whether hedging or speculating on near-term direction.
Shifting to healthcare, Moderna is drawing serious attention in the options pit, with over twenty-five thousand contracts traded representing roughly two and a half million underlying shares. That volume clocks in at nearly forty-eight percent of the stock's average daily share count, suggesting the market is bracing for a meaningful move in the biotech name.
Away from the tape, a federal judge has handed Harvard a significant legal victory, tossing the Trump administration's antisemitism lawsuit against the university. That suit had been the foundation for the administration's push to force financial and policy concessions from Harvard over pro-Palestinian protests in twenty twenty-three and twenty twenty-four. The ruling removes a key piece of leverage in that ongoing standoff.
That's the tape. Markets Desk, signing off the floor.
